Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.09
GTIV's Cash to Debt is ranked higher than
60% of the 248 Companies
in the Global Medical Care industry.

( Industry Median: 0.19 vs. GTIV: 0.09 )
GTIV' s 10-Year Cash to Debt Range
Min: 0.02   Max: No Debt
Current: 0.09

Equity to Asset -0.23
GTIV's Equity to Asset is ranked lower than
53% of the 248 Companies
in the Global Medical Care industry.

( Industry Median: 0.49 vs. GTIV: -0.23 )
GTIV' s 10-Year Equity to Asset Range
Min: -0.24   Max: 0.75
Current: -0.23

-0.24
0.75
F-Score: 3
Z-Score: 0.27
M-Score: -4.12
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) -16.15
GTIV's Operating margin (%) is ranked lower than
51% of the 250 Companies
in the Global Medical Care industry.

( Industry Median: 9.51 vs. GTIV: -16.15 )
GTIV' s 10-Year Operating margin (%) Range
Min: -30.56   Max: 9.38
Current: -16.15

-30.56
9.38
Net-margin (%) -20.61
GTIV's Net-margin (%) is ranked lower than
52% of the 250 Companies
in the Global Medical Care industry.

( Industry Median: 5.53 vs. GTIV: -20.61 )
GTIV' s 10-Year Net-margin (%) Range
Min: -34.69   Max: 12.38
Current: -20.61

-34.69
12.38
ROA (%) -31.00
GTIV's ROA (%) is ranked lower than
53% of the 250 Companies
in the Global Medical Care industry.

( Industry Median: 4.08 vs. GTIV: -31.00 )
GTIV' s 10-Year ROA (%) Range
Min: -43.19   Max: 18.71
Current: -31

-43.19
18.71
ROC (Joel Greenblatt) (%) -273.80
GTIV's ROC (Joel Greenblatt) (%) is ranked lower than
54% of the 250 Companies
in the Global Medical Care industry.

( Industry Median: 18.48 vs. GTIV: -273.80 )
GTIV' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -562.8   Max: 132.63
Current: -273.8

-562.8
132.63
Revenue Growth (%) 5.20
GTIV's Revenue Growth (%) is ranked higher than
71% of the 205 Companies
in the Global Medical Care industry.

( Industry Median: 7.50 vs. GTIV: 5.20 )
GTIV' s 10-Year Revenue Growth (%) Range
Min: -26.3   Max: 13
Current: 5.2

-26.3
13
» GTIV's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

GTIV Guru Trades in Q3 2013

Mario Gabelli 972,200 sh (+4.68%)
Chuck Royce 23,000 sh (unchged)
Joel Greenblatt 193,536 sh (-16.1%)
Jim Simons 150,516 sh (-23.95%)
David Dreman 117,669 sh (-71.49%)
» More
Q4 2013

GTIV Guru Trades in Q4 2013

Paul Tudor Jones 13,200 sh (New)
Jim Simons 174,216 sh (+15.75%)
David Dreman 134,335 sh (+14.16%)
Joel Greenblatt 198,153 sh (+2.39%)
Mario Gabelli 977,200 sh (+0.51%)
Chuck Royce 23,000 sh (unchged)
» More
Q1 2014

GTIV Guru Trades in Q1 2014

David Dreman 138,616 sh (+3.19%)
Jim Simons 178,609 sh (+2.52%)
Chuck Royce 23,000 sh (unchged)
Paul Tudor Jones Sold Out
Joel Greenblatt Sold Out
Mario Gabelli 963,700 sh (-1.38%)
» More
Q2 2014

GTIV Guru Trades in Q2 2014

David Abrams 975,170 sh (New)
David Dreman 186,139 sh (+34.28%)
Chuck Royce Sold Out
Jim Simons 177,527 sh (-0.61%)
Mario Gabelli 923,500 sh (-4.17%)
» More
» Details

Insider Trades

Latest Guru Trades with GTIV

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
David Abrams 2014-06-30 New Buy1%$7.52 - $16.05 $ 19.2472%975170
David Dreman 2014-06-30 Add 34.28%0.05%$7.52 - $16.05 $ 19.2472%186139
Joel Greenblatt 2014-03-31 Sold Out 0.06%$8.67 - $12.49 $ 19.2480%0
David Dreman 2013-09-30 Reduce -71.49%0.11%$8.6 - $13.73 $ 19.2470%117669
Joel Greenblatt 2013-06-30 Add 23.09%0.02%$9.32 - $11.77 $ 19.2485%230677
David Dreman 2013-03-31 New Buy0.14%$9.44 - $12.62 $ 19.2477%487716
Joel Greenblatt 2013-03-31 Add 273.1%0.07%$9.44 - $12.62 $ 19.2477%187403
Mario Gabelli 2013-03-31 Add 34.03%0.01%$9.44 - $12.62 $ 19.2477%818900
Joel Greenblatt 2012-12-31 Reduce -25.46%0.01%$9.37 - $11.36 $ 19.2488%50229
Joel Greenblatt 2012-09-30 New Buy0.05%$6.11 - $12.57 $ 19.24108%67382
Mario Gabelli 2012-03-31 Add 77.53%0.02%$6.45 - $8.83 $ 19.24168%640000
Joel Greenblatt 2011-12-31 Sold Out 0.03%$3.02 - $7.18 $ 19.24283%0
Joel Greenblatt 2011-09-30 Add 152.07%0.02%$5.3 - $21.05 $ 19.2470%34609
Ken Fisher 2011-09-30 Sold Out 0.0075%$5.3 - $21.05 $ 19.2470%0
Mario Gabelli 2011-09-30 Add 26.78%$5.3 - $21.05 $ 19.2470%350300
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/S 0.36
GTIV's P/S is ranked higher than
93% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 1.53 vs. GTIV: 0.36 )
GTIV' s 10-Year P/S Range
Min: 0.06   Max: 0.77
Current: 0.36

0.06
0.77
PFCF 16.64
GTIV's PFCF is ranked higher than
85% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 43.00 vs. GTIV: 16.64 )
GTIV' s 10-Year PFCF Range
Min: 2.1   Max: 62.17
Current: 16.64

2.1
62.17
EV-to-EBIT -5.83
GTIV's EV-to-EBIT is ranked higher than
52% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 25.29 vs. GTIV: -5.83 )
GTIV' s 10-Year EV-to-EBIT Range
Min: 5.7   Max: 27.3
Current: -5.83

5.7
27.3
Current Ratio 1.32
GTIV's Current Ratio is ranked higher than
70% of the 250 Companies
in the Global Medical Care industry.

( Industry Median: 1.40 vs. GTIV: 1.32 )
GTIV' s 10-Year Current Ratio Range
Min: 1.25   Max: 3.47
Current: 1.32

1.25
3.47
Quick Ratio 1.32
GTIV's Quick Ratio is ranked higher than
73% of the 250 Companies
in the Global Medical Care industry.

( Industry Median: 1.28 vs. GTIV: 1.32 )
GTIV' s 10-Year Quick Ratio Range
Min: 1.25   Max: 3.29
Current: 1.32

1.25
3.29

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 2.19
GTIV's Price/DCF (Projected) is ranked higher than
78% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 2.81 vs. GTIV: 2.19 )
GTIV' s 10-Year Price/DCF (Projected) Range
Min: 0.25   Max: 5.09
Current: 2.19

0.25
5.09
Price/Median PS Value 0.76
GTIV's Price/Median PS Value is ranked higher than
95% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 1.19 vs. GTIV: 0.76 )
GTIV' s 10-Year Price/Median PS Value Range
Min: 0.14   Max: 1.54
Current: 0.76

0.14
1.54
Earnings Yield (Greenblatt) 6.30
GTIV's Earnings Yield (Greenblatt) is ranked higher than
76% of the 241 Companies
in the Global Medical Care industry.

( Industry Median: 5.30 vs. GTIV: 6.30 )
GTIV' s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.7   Max: 17.5
Current: 6.3

3.7
17.5
Forward Rate of Return (Yacktman) 9.26
GTIV's Forward Rate of Return (Yacktman) is ranked higher than
75% of the 216 Companies
in the Global Medical Care industry.

( Industry Median: 9.81 vs. GTIV: 9.26 )
GTIV' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 2.7   Max: 59.9
Current: 9.26

2.7
59.9

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:GHT.Germany
Gentiva Health Services, Inc., is a provider of home health services & hospice services serving patients throughout the United States. The Company provides a single source for skilled nursing; physical, occupational, speech and neurorehabilitation services; hospice services; social work; nutrition; disease management education; help with daily living activities; and other therapies and services. The Company's operations involve servicing patients and customers through its Home Health segment and Hospice segment. The Home Health segment is comprised of direct home nursing and therapy services operations, including specialty programs and its consulting business. The Company conducts direct home nursing and therapy services operations through licensed and Medicare-certified agencies from which the Company provides various combinations of skilled nursing and therapy services and paraprofessional nursing services to adult and elder patients. Reimbursement sources primarily include government programs, such as Medicare and Medicaid, and private sources, such as health insurance plans, managed care organizations, long term care insurance plans and personal funds. The Company's Hospice segment serves terminally ill patients and their families through more than 165 locations operating in 30 states. Depending on a patient's needs, each hospice patient is assigned an interdisciplinary team comprised of a physician, nurse(s), home health aide(s), medical social worker(s), chaplain, dietary counselor and bereavement coordinator, as well as other care professionals. Hospice services are provided primarily in the patient's home or other residence, such as an assisted living residence or nursing home, or in a hospital. The Medicare hospice benefit is designed for patients expected to live six months or less. Hospice services for a patient can continue, however, for more than six months, so long as the patient remains eligible as reflected by a physician's certification. The Company's home health and hospice businesses obtain patients and clients through personal and corporate sales presentations, telephone marketing calls, direct mail solicitation, referrals from other clients and advertising in a variety of local and national media, including the Yellow Pages, newspapers, magazines, trade publications and radio. The home health services industry in which the Company operates is highly competitive and fragmented. The Company's primary competitors for its home healthcare business are hospital-based home health agencies, local home health agencies and visiting nurse associations. The Company's business is subject to extensive federal, state and, in some instances, local regulations and standards which govern Medicare, Medicaid, TRICARE and other government-funded reimbursement programs.
» More Articles for GTIV

Headlines

Articles On GuruFocus.com
Gabelli Increases Holdings in Struggling Gentiva Health Services Jun 21 2013 
“Powerball” Ideas - Home Healthcare Companies: AFAM, GTIV, LHCG, AMED Jan 05 2012 
Very Low P/E Stocks Joel Greenblatt selected Dec 22 2011 
Almost Family: The Magic Formula Stock is getting cheaper and cheaper Dec 11 2011 
5 Magic Formula Stocks With High Debt Burdens Oct 06 2011 
Gentiva Health Services Inc. Reports Operating Results (10-Q) Nov 12 2010 
Gentiva Health Services Inc. Reports Operating Results (10-Q) Jul 30 2010 
Gentiva Health Services Inc. Reports Operating Results (10-Q) May 13 2010 
Gentiva Health Services Inc. (GTIV) EVP, CFO & Treasurer John R Potapchuk sells 21,133 Shares Apr 15 2010 
Gentiva Health Services Inc. (GTIV) EVP, CFO & Treasurer John R Potapchuk sells 32,749 Shares Mar 19 2010 


More From Other Websites
INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Gentiva... Oct 20 2014
GENTIVA HEALTH SERVICES, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of... Oct 16 2014
Lifshitz & Miller Law Firm Announces Investigation of Apco Oil & Gas International Inc., Arrowhead... Oct 15 2014
GENTIVA HEALTH SERVICES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change... Oct 14 2014
INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Gentiva... Oct 14 2014
SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Gentiva Health... Oct 13 2014
GENTIVA HEALTH SERVICES, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of... Oct 10 2014
How Will Kindred Healthcare (KND) Stock React Today to This Upgrade? Oct 10 2014
Gentiva Agrees on Acquisition by Kindred, Shares Rise Oct 10 2014
Gentiva Awaits Acquisition; Inorganic Growth Compelling Oct 10 2014
Will Gentiva (GTIV) Continue to Surge Higher? Oct 10 2014
Gentiva Health Services (GTIV) Soars: Stock Rises 16.6% Oct 10 2014
[$$] Corporate Watch: News Digest Oct 09 2014
[$$] CORPORATE WATCH Oct 09 2014
Updated: Harwood Feffer LLP Announces Investigation of Gentiva Health Services, Inc. Oct 09 2014
GENTIVA (GTIV) SHAREHOLDER ALERT - Oct 09 2014
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Gentiva Health Services,... Oct 09 2014
Gentiva Health Services, Inc. -- Moody's reviews Gentiva's B3 CFR for upgrade on pending acquisition... Oct 09 2014
Today's Market Thorns, Roses, and All Time Highs... Oct 09 2014
Gap and Ruby Tuesday are big market movers Oct 09 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK